# Xbrane Biopharma AB

> Biopharmaceuticals and generics production

Business model and tags: B2B, Publicly traded, Pharma & life sciences, Has in-house R&D

## About Xbrane Biopharma AB

Biopharmaceutical company specializing in biosimilars and long-acting injectables, focusing on global health equality through affordable treatments for critical diseases

## Key facts

- **Industry**: Biotechnology
- **Company size**: 11–50 employees
- **Headquarters**: Solna, Stockholm, Sweden
- **Founded**: 2008
- **Revenue**: SEK 152M (FY2025, publicly reported)
- **Website**: [xbrane.com](http://xbrane.com/en/)
- **LinkedIn**: [linkedin.com/company/xbrane-biopharma-ab](https://www.linkedin.com/company/xbrane-biopharma-ab)

## Xbrane Biopharma AB at a glance

Xbrane Biopharma AB is a B2B company in the Biotechnology industry, headquartered in Solna, Stockholm, Sweden.

Xbrane Biopharma AB was founded in 2008.

Xbrane Biopharma AB has 11–50 employees.

Xbrane Biopharma AB's revenue is SEK 152M (FY2025, publicly reported).

## Frequently asked questions about Xbrane Biopharma AB

### What is Xbrane Biopharma AB's revenue?

Xbrane Biopharma AB's revenue is SEK 152M (FY2025, publicly reported).

### How many employees does Xbrane Biopharma AB have?

Xbrane Biopharma AB has 11–50 employees.

### Where is Xbrane Biopharma AB headquartered?

Xbrane Biopharma AB is headquartered in Solna, Stockholm, Sweden.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/xbrane-biopharma-ab
